The opioid settlement, which resulted in billions of dollars from major pharmaceutical companies like Johnson & Johnson, McKesson, Cardinal Health, and AmerisourceBergen, is designed to address the opioid crisis by funding addiction treatment, prevention, and recovery efforts. Critics argue that the distribution process lacks transparency and being misdirected toward administrative costs rather than direct support for addiction recovery.
In this episode I discuss the opioid settlement, where the money is going and what is currently the state of the opioid crisis in America.
→FOLLOW ON SOCIAL MEDIA←
Youtube
Instagram
Facebook
Twitter
Linked In
#thepeoplesvoicepodcast
#social issues
Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research
